Interview with Urs Flueckiger, President, Roche South Korea
You are one of the foreign multinational directors with most time in the Korean pharmaceutical industry, since 2003. What is your assessment of the direction the market has taken in…
Korean Pharmaceutical Association (KPA) is a non-profit organization established as Korea Pharmacists Association in 1928. Approximately 60,000 members of KPA have contributed to public health through ‘good quality of medicine and right medication’. With our belief and willingness to improve public health, members of KPA are committed to build a welfare country.
KPA has 16 regional divisions (5 special divisions abroad), 227 branches, General Assembly of Delegates as a legislative body, and 16 standing committees as an executive organization.
KPA has made efforts that pharmacies as the closest health care provider offer good quality of public health care service. KPA has tried to keep the policy of separation of dispensary from medical practice, offer on-going education to pharmacists, renovate and develop pharmacology, improve national health insurance, establish fair trade of medical supplies, promote an information-oriented pharmacology, and build a computerized pharmacy.
In addition, KPA supports various social programs and makes efforts to build social safety networks such as smoking cessation campaign, child protection program, 1388 youth protection campaign, and more.
KPA will try to develop public health service system combining public interests with pharmacists’ right and do the best effort to complete roles of pharmacists under the slogan of ‘pharmacists with pride. KPA in company with public’.
Contact details
Address: 1493-3 Seocho-3 Dong, Seocho-gu, Seoul 137-869 KOREA
Tel: +82 02 581 1201
www.kpanet.or.kr
You are one of the foreign multinational directors with most time in the Korean pharmaceutical industry, since 2003. What is your assessment of the direction the market has taken in…
What is KHIDI’s role in supporting the development of the Korean health industry? KHIDI performs three major roles in supporting the Korean health industry, which includes pharmaceuticals, medical devices, cosmetics,…
Previous to your current position as President of Pfizer Korea since 2004, you had been in the country between 1989 and 1993 as sales and marketing director. How different are…
Please introduce Handok Pharmaceuticals to our readers, and in particular how it has evolved through partnerships with different multinational companies throughout its history. Handok has developed in a very unique…
Korea had a late start, but is now one of the global hot spots for clinical trials. How would you sum up and explain this quick evolution? Clinical trials in…
You have been in South Korea for several months, following some time as Merck’s President in Pakistan. In your opinion, what do you find as the most interesting aspects of…
What was the vision behind the creation of Neurotech back in 1998, originally as a Research Center, and then as an independent bio-tech company? It all began in 1998 when…
You have recently been appointed as General Manager of Servier in South Korea, after coming from several years working in Europe. What perception did you have of the far-way Korean…
Already an economic powerhouse thriving on export-driven industries such as electronics, automotive and ship-building, South Korea is now looking to boost its potential in the life sciences and to…
Over the last several years we have seen a shift in clinical research from traditional healthcare markets to Asia. How do you see this trend evolving in the coming years?…
See our Cookie Privacy Policy Here